Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9B2Z3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.770 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.513 |
CLV_NRD_NRD_1 | 316 | 318 | PF00675 | 0.808 |
CLV_NRD_NRD_1 | 385 | 387 | PF00675 | 0.618 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.346 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.650 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.801 |
CLV_PCSK_KEX2_1 | 394 | 396 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.650 |
CLV_PCSK_PC1ET2_1 | 318 | 320 | PF00082 | 0.801 |
CLV_PCSK_PC1ET2_1 | 394 | 396 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.711 |
CLV_PCSK_SKI1_1 | 368 | 372 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 394 | 398 | PF00082 | 0.614 |
DEG_APCC_DBOX_1 | 241 | 249 | PF00400 | 0.672 |
DEG_APCC_DBOX_1 | 385 | 393 | PF00400 | 0.617 |
DEG_COP1_1 | 373 | 383 | PF00400 | 0.647 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.695 |
DEG_SCF_FBW7_1 | 281 | 288 | PF00400 | 0.727 |
DEG_SCF_FBW7_2 | 342 | 348 | PF00400 | 0.729 |
DEG_SPOP_SBC_1 | 84 | 88 | PF00917 | 0.684 |
DOC_CKS1_1 | 282 | 287 | PF01111 | 0.697 |
DOC_CKS1_1 | 342 | 347 | PF01111 | 0.738 |
DOC_CYCLIN_RxL_1 | 206 | 214 | PF00134 | 0.473 |
DOC_CYCLIN_RxL_1 | 391 | 400 | PF00134 | 0.629 |
DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.752 |
DOC_MAPK_gen_1 | 165 | 173 | PF00069 | 0.625 |
DOC_PP2B_LxvP_1 | 339 | 342 | PF13499 | 0.623 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.741 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.587 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.643 |
DOC_USP7_MATH_1 | 274 | 278 | PF00917 | 0.771 |
DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.699 |
DOC_USP7_MATH_1 | 322 | 326 | PF00917 | 0.530 |
DOC_USP7_MATH_1 | 330 | 334 | PF00917 | 0.787 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.573 |
DOC_USP7_UBL2_3 | 298 | 302 | PF12436 | 0.795 |
DOC_USP7_UBL2_3 | 305 | 309 | PF12436 | 0.711 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.637 |
DOC_WW_Pin1_4 | 267 | 272 | PF00397 | 0.768 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.642 |
DOC_WW_Pin1_4 | 293 | 298 | PF00397 | 0.627 |
DOC_WW_Pin1_4 | 341 | 346 | PF00397 | 0.755 |
LIG_14-3-3_CanoR_1 | 175 | 180 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 194 | 202 | PF00244 | 0.342 |
LIG_14-3-3_CanoR_1 | 368 | 373 | PF00244 | 0.524 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.656 |
LIG_14-3-3_CanoR_1 | 85 | 90 | PF00244 | 0.720 |
LIG_BRCT_BRCA1_1 | 8 | 12 | PF00533 | 0.443 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.504 |
LIG_FHA_1 | 335 | 341 | PF00498 | 0.799 |
LIG_FHA_2 | 345 | 351 | PF00498 | 0.629 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.535 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.537 |
LIG_LIR_Apic_2 | 116 | 121 | PF02991 | 0.683 |
LIG_LIR_Gen_1 | 199 | 210 | PF02991 | 0.479 |
LIG_LIR_Gen_1 | 376 | 384 | PF02991 | 0.593 |
LIG_LIR_Nem_3 | 10 | 16 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.647 |
LIG_LIR_Nem_3 | 199 | 205 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 376 | 380 | PF02991 | 0.589 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.482 |
LIG_MLH1_MIPbox_1 | 9 | 13 | PF16413 | 0.422 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.447 |
LIG_SH2_NCK_1 | 202 | 206 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.456 |
LIG_SH3_1 | 111 | 117 | PF00018 | 0.714 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.772 |
LIG_SH3_3 | 265 | 271 | PF00018 | 0.777 |
LIG_SH3_3 | 286 | 292 | PF00018 | 0.703 |
LIG_SH3_3 | 339 | 345 | PF00018 | 0.722 |
LIG_SH3_3 | 377 | 383 | PF00018 | 0.672 |
LIG_SH3_4 | 298 | 305 | PF00018 | 0.615 |
LIG_SUMO_SIM_anti_2 | 14 | 21 | PF11976 | 0.447 |
LIG_SUMO_SIM_anti_2 | 352 | 360 | PF11976 | 0.545 |
LIG_SUMO_SIM_par_1 | 209 | 214 | PF11976 | 0.474 |
LIG_TRAF2_1 | 197 | 200 | PF00917 | 0.561 |
LIG_TRAF2_1 | 61 | 64 | PF00917 | 0.482 |
MOD_CDK_SPK_2 | 293 | 298 | PF00069 | 0.538 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.789 |
MOD_CK1_1 | 325 | 331 | PF00069 | 0.757 |
MOD_CK1_1 | 335 | 341 | PF00069 | 0.718 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.487 |
MOD_CK2_1 | 200 | 206 | PF00069 | 0.612 |
MOD_CK2_1 | 344 | 350 | PF00069 | 0.633 |
MOD_CK2_1 | 357 | 363 | PF00069 | 0.518 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.483 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.484 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.758 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.568 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.588 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.555 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.776 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.778 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.804 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.750 |
MOD_GlcNHglycan | 372 | 375 | PF01048 | 0.703 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.782 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.716 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.789 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.522 |
MOD_GSK3_1 | 303 | 310 | PF00069 | 0.807 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.643 |
MOD_GSK3_1 | 330 | 337 | PF00069 | 0.681 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.628 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.525 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.233 |
MOD_NEK2_1 | 357 | 362 | PF00069 | 0.637 |
MOD_NEK2_1 | 370 | 375 | PF00069 | 0.571 |
MOD_NEK2_1 | 69 | 74 | PF00069 | 0.499 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.473 |
MOD_PIKK_1 | 155 | 161 | PF00454 | 0.646 |
MOD_PIKK_1 | 274 | 280 | PF00454 | 0.654 |
MOD_PIKK_1 | 332 | 338 | PF00454 | 0.742 |
MOD_PIKK_1 | 397 | 403 | PF00454 | 0.571 |
MOD_PKA_1 | 167 | 173 | PF00069 | 0.349 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.641 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.619 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.599 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.727 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.550 |
MOD_Plk_2-3 | 70 | 76 | PF00069 | 0.586 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.355 |
MOD_Plk_4 | 184 | 190 | PF00069 | 0.504 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.799 |
MOD_Plk_4 | 7 | 13 | PF00069 | 0.444 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.640 |
MOD_ProDKin_1 | 267 | 273 | PF00069 | 0.770 |
MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.641 |
MOD_ProDKin_1 | 293 | 299 | PF00069 | 0.623 |
MOD_ProDKin_1 | 341 | 347 | PF00069 | 0.745 |
MOD_SUMO_for_1 | 300 | 303 | PF00179 | 0.738 |
MOD_SUMO_rev_2 | 214 | 222 | PF00179 | 0.622 |
TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.472 |
TRG_DiLeu_BaEn_1 | 353 | 358 | PF01217 | 0.650 |
TRG_DiLeu_BaLyEn_6 | 392 | 397 | PF01217 | 0.480 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.477 |
TRG_ER_diArg_1 | 110 | 113 | PF00400 | 0.770 |
TRG_ER_diArg_1 | 253 | 256 | PF00400 | 0.590 |
TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.562 |
TRG_NLS_MonoExtC_3 | 110 | 115 | PF00514 | 0.801 |
TRG_Pf-PMV_PEXEL_1 | 209 | 214 | PF00026 | 0.474 |
TRG_Pf-PMV_PEXEL_1 | 394 | 398 | PF00026 | 0.573 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4N7 | Leptomonas seymouri | 56% | 100% |
A0A1X0NU71 | Trypanosomatidae | 36% | 100% |
A0A3Q8ITD1 | Leishmania donovani | 92% | 100% |
A0A3R7KNF2 | Trypanosoma rangeli | 36% | 100% |
A4HKK3 | Leishmania braziliensis | 81% | 100% |
A4I835 | Leishmania infantum | 91% | 100% |
D0AAA2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
Q4Q563 | Leishmania major | 91% | 100% |
V5BKQ1 | Trypanosoma cruzi | 35% | 100% |